Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7700 |
Lersivirine
3-氰基-5-[[3,5-二乙基-1-(2-羟基乙基)-1H-吡唑-4-基]氧基]苯腈,Lersivirine(UK 453061),UK-453061 |
HIV Protease; Reverse Transcriptase | Microbiology/Virology; Proteases/Proteasome |
Lersivirine (UK-453061) 是非核苷逆转录的抑制剂 (NNRTI),有效抑制 NNRTI 耐药病毒。它对野生型人类免疫缺陷病毒和临床相关 NNRTI 耐药菌株显示出强大的抗逆转录病毒活性。 | |||
T9223 |
RO-0335
|
Reverse Transcriptase | Microbiology/Virology |
RO-0335 是新高效二苯醚非核苷逆转录酶抑制剂。它 (IC50= 1.1 nM) 可以抑制Wt HIV-1病毒,对 92% 的 NNRTI 耐药临床分离株具有保留活性 (IC50<100 nM)。 | |||
T27442 |
GSK 224876
GSK-224876,GSK224876 |
||
GSK 224876 is a novel next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI). It has activity against efavirenz-resistant strains in the treatment of treatment-naive HIV-1-infected subjects. | |||
T63677 | HIV-1 inhibitor-13 | ||
HIV-1 inhibitor-13 是口服具有活力的 HIV-1 非核苷逆转录酶抑制剂 (NNRTI),对 HIV-1 RT 的 IC50值为 0.14 μM。HIV-1 inhibitor-13 对HIV-1耐药株具有活性 (EC50: 2.85-18.0 nM)。 | |||
T78749 | HIV-1 inhibitor-57 | ||
HIV-1 inhibitor-57(Compound 12g)是抗HIV药物。该化合物对野生型及五种常见NNRTI耐药HIV-1株均表现出抗病毒活性,具有0.024至0.0010 μM的EC 50值。HIV-1 inhibitor-57能够与HIV-1RT的结合位点附近残基形成附加相互作用。 | |||
T61311 |
HIV-1 inhibitor-30
|
||
HIV-1 inhibitor-30 (compound 10i) is a potent inhibitor of HIV-1, specifically targeting the RT DNA polymerase enzyme. It exhibits strong antiretroviral activity, with an EC 50 value of 40 nM and an IC 50 value of 80 nM. Furthermore, HIV-1 inhibitor-30 demonstrates significant effectiveness against seven NNRTI-resistant strains of HIV-1 (RT-K103N; RT-Y181C; RT-K103N, Y181C; RT-L100I, K103N; RT-Y188L; RT-K103N, G190A; RT-K103N, V108I), with IC 50 values ranging from 0.04 to 1.42 μM. This compound... | |||
T78925 |
HIV-1 inhibitor-58
|
||
HIV-1inhibitor-58(Compound 10c)是一款抗逆转录病毒活性的广谱非核苷逆转录酶抑制剂,有效抑制MT-4细胞中的HIV-1 WT株IIIB以及NNRTI耐药菌株,如K103N和E138K(EC50 < 50 nM)。此外,HIV-1inhibitor-58对CYP2C9与CYP2C19也表现出抑制作用(IC50分别为2.06 μM与1.91 μM),适用于HIV感染研究。 |